Antitrust enforcers argue that the healthcare giant’s latest deal would illegally harm competition.

Minnesota-based UnitedHealth Group Inc. is the focus of an antitrust lawsuit filed on Tuesday by the United States Department of Justice.

The U.S. Department of Justice and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion acquisition of Amedisys Inc , citing concerns that the deal would reduce competition in the home health services market.

The U.S. Department of Justice (DOJ) and four state attorneys general filed a lawsuit to block UnitedHealth Group’s (NYSE: UNH) acquisition of Amedisys

UnitedHealth Group's Optum said the Justice Department's lawsuit to stop its acquisition of Amedisys is an overreach.

The U.S. Justice Department and four states sued Tuesday to block UnitedHealth Group’s proposed $3.3 billion acquisition of Amedisys, a Louisiana-based home health company that would further United’s push into the home care and hospice markets.

The U.S. Department of Justice and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion acquisition of Amedisys Inc, citing concerns that the deal would reduce competition in the home health services market.

The government is citing concerns the deal would hinder access to home health and hospice services in the U.S.

The U.S. Department of Justice (DOJ) recently filed a lawsuit to block UnitedHealth Group Incorporated’s UNH $3.3 billion acquisition of Amedisys, Inc. AMED, arguing that the merger would hurt competition in the home health and hospice care market.